Miguel Angelo Martins Moreira

10PUBLICATIONS
32CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer geneticsEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 25, 2025
Associations between genetic HPV 16 diversity and cervical cancer prognosis.

Patrícia Patury, Fabio B Russomano, Miguel Angelo Martins Moreira

|May 14, 2025
ESR1 overexpression is a biomarker of relapse and worse prognosis in stage I endometrioid endometrial carcinoma.

C B P Chaves, P Nicolau-Neto, T A Simão

|Jul 26, 2024
Exploring cross-tissue DNA methylation patterns: blood-brain CpGs as potential neurodegenerative disease biomarkers.

Vanessa Mendonça, Sheila Coelho Soares-Lima, Miguel Angelo Martins Moreira

|Jun 12, 2024
Importance of genetic cancer risk assessment as a strategy to stratify risk and provide precision prevention in high-risk patients and families.

Patricia Ashton-Prolla, Maria Isabel Waddington Achatz, Miguel Angelo Martins Moreira

|Feb 03, 2024
BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.

Caroline Stahnke Richau, Nicole de Miranda Scherer, Bruna Palma Matta

|Sep 08, 2023
Human Papillomavirus 16 Lineage D is Associated with High Risk of Cervical Cancer in the Brazilian Northeast Region.

Luís Felipe Leite Martins, Miguel Ângelo Martins Moreira, Rodrigo Alves Pinto

Pageof 2